revealed that the inhibition of AHSA1 expression in mice models of Alzheimer’s disease and in vitro cell models can eliminate the accumulation of Tau protein caused by Hsp90, which is expected to become a new therapeutic target for Alzheimer’s disease (10). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.